Krystal Biotech Announces Pricing of Upsized Initial Public Offering
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/18/2026
- Tech selloff weighs down Wall Street as bond yields climb
- Baidu slips as Q2 results miss estimates despite growth in AI cloud business
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
- Home Depot beats estimates, reaffirms fiscal 2026 guidance
- Citi says positioning risk is shifting from short squeezes to profit-taking
- Wall Street indexes slip as oil prices rise, retail results awaited
- Tech selloff weighs down Wall Street as bond yields climb
- Micron rises as White House presses Apple to avoid Chinese memory chips
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- Francisco Partners to acquire Weave Communications for $650M
Krystal Biotech (KRYS) IPO Opens Modestly Higher
September 20, 2017 11:31 AM EDTToday's IPO for Krystal Biotech (NASDAQ: KRYS) opened for trading at $10.50 after pricing 3,960,000 shares of common stock at a price to the public of $10.00 per share.
In addition, Krystal has granted the underwriters a 30-day option to purchase up to an additional 594,000... More
